Glenmark Abirapro 250 mg Abiraterone Acetate Tablets About
Introducing Glenmark Abirapro 250 mg Abiraterone Acetate Tablets, a masterful oncology solution designed for adults battling metastatic prostate cancer. Each bottle, crafted for excellence, contains 120 inestimable white tablets, ensuring a reliable and potent dosage of 250 mg per tablet. Originating from India, Abirapro is an allopathic anticancer agent requiring a prescription and is intended for oral use by men. With a shelf life of 24 months and housed in a secure plastic bottle, this special product is in limited stock-grab yours while supplies last!
Special Features & Areas of Application
Glenmark Abirapro 250 mg Tablets feature exceptional purity and consistent pharmacological efficacy, making them an excellent choice for advanced prostate cancer care. The tablets are administered orally and target systemic cancer cells throughout the body. The recommended application area is for adult men suffering from metastatic prostate cancer, under the guidance of a medical professional. Their convenient bottle packaging and secure storage requirements further enhance safety and usability.
Sample Policy & Supply Capability
Sample requests for Glenmark Abirapro 250 mg Tablets are welcome, subject to the asking price and company terms. The supplier maintains robust supply ability to cater to the domestic market efficiently, with logistics solutions to ensure safe goods transport. Availability may vary depending on regional demand and distributor stock levels, so it is recommended to inquire directly for the latest updates on sample accessibility and delivery timelines.
FAQ's of Glenmark Abirapro 250 mg Abiraterone Acetate Tablets:
Q: How should Glenmark Abirapro 250 mg Abiraterone Acetate Tablets be taken?
A: These tablets must be taken orally, usually on an empty stomach, as directed by a healthcare professional. Always follow your doctor's dosage and administration guidelines for best results.
Q: What is the primary benefit of using Abirapro 250 mg?
A: Abirapro 250 mg is especially effective in the treatment of metastatic prostate cancer. It helps inhibit the production of specific hormones involved in cancer growth, thereby improving patient outcomes.
Q: When is Glenmark Abirapro recommended for patients?
A: This medication is recommended for adult men diagnosed with advanced or metastatic prostate cancer and should be used only with a valid prescription from a qualified physician.
Q: Where should Glenmark Abirapro tablets be stored?
A: Store the tablets below 30C in a dry place. Keep the bottle tightly closed to protect it from moisture and ensure the medication's effectiveness throughout its shelf life.
Q: What is the process to obtain a sample of Glenmark Abirapro 250 mg?
A: To request a sample, contact the supplier or trader directly. Samples may be provided upon evaluation of your requirements and agreement on the asking price, subject to company policy and supply conditions.